Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs Ralph Lauren Corp (RL) Price & Performance

Ralph Lauren CorpTrade

Price performance (Past 24H)

Key statistics

GSK plc vs Ralph Lauren Corp — how do they compare? GSK plc trades at $50.55 (market cap $102.60B), while Ralph Lauren Corp trades at $397.75 (market cap $23.70B). The key difference: GSK plc is far larger — about 4.3× Ralph Lauren Corp's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.

GSKRL
Market Cap
$102.60B$23.70B
Sector
HealthConsumer Cyclical
52-Week High
$61.18$414.25
52-Week Low
$38.22$285.35
Enterprise Value
$123.04B$24.76B
Dividend Yield
3.57%0.94%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK

About Ralph Lauren Corp

Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.

Read more on RL